Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.3
8181 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Talks at GS
View all
Insights Now
94 Listeners
Masters in Business
2,174 Listeners
Exchanges
992 Listeners
Capital Allocators – Inside the Institutional Investment Industry
804 Listeners
UBS On-Air: Market Moves
181 Listeners
Making Sense
58 Listeners
Value Investing with Legends
196 Listeners
Thoughts on the Market
1,271 Listeners
Dry Powder: The Private Equity Podcast
146 Listeners
At Any Rate
80 Listeners
The Memo by Howard Marks
417 Listeners
Global Data Pod
24 Listeners
The Credit Edge by Bloomberg Intelligence
26 Listeners
The Markets
70 Listeners
Bloomberg Talks
17 Listeners